Ingrid A. Binswanger, MD, MPH, MS


Adjunct Professor

Department of Health Systems Science

Dr. Ingrid A. Binswanger is a Senior Investigator at the Institute for Health Research and a practicing physician in Chemical Dependency Treatment Services with Kaiser Permanente Colorado. Her peer-reviewed research focuses on how to reduce the medical complications of opioid analgesic use and substance use, such as overdose. She also conducts research to reduce the morbidity and mortality of people who have been involved with the criminal justice system. Dr. Binswanger is also an Associate Professor in the Division of General Internal Medicine and an Affiliate Member of the Division of Substance Dependence at the University of Colorado School of Medicine. She also serves as a Senior Editor of the peer-reviewed journal Addiction.

Faculty profile headshot of Ingrid A. Binswanger, MD, MPH, MS

Education and Training

BA, with distinction, Swarthmore College
MS, School of Public Health, University of California, Berkeley
MD, University of California, Berkeley-University of California, San Francisco Joint Medical Program
MPH, University of Washington, Seattle
Resident, Primary Care General Internal Medicine, University of California, San Francisco
Fellow, Robert Wood Johnson Clinical Scholars Program, University of Washington

Professional Positions

Clinical Instructor in Medicine, Division of General Internal Medicine, Department of Medicine
University of Washington
Attending Physician, Division of General Internal Medicine
Madison Clinic at Harborview
Assistant Professor of Medicine, Division of General Internal Medicine, Department of Medicine
University of Colorado, Denver/Aurora
Attending Physician, General Internal Medicine
Bernard F. Gipson Eastside Family Health Center-Denver Health Medical Center
Attending Physician
Potomac Street Center, Addiction Research and Treatment Services, University of Colorado School of Medicine
Co-Director, Primary Care Research Fellowship Program
University of Colorado School of Medicine
2009-2012; 2017-2018
Primary Care Residency Research Director
Primary Care Internal Medicine Residency Program, University of Colorado School of Medicine
Director, Primary Care Research Fellowship Program
University of Colorado School of Medicine
Associate Professor of Medicine, Division of General Internal Medicine, Department of Medicine
University of Colorado School of Medicine
Director, Patient Centered Outcomes Research (PCOR) Training Program
University of Colorado School of Medicine-Denver Health Medical Center
Senior Investigator, Institute for Health Research
Kaiser Permanente Colorado
Colorado Permanente Medical Group, Chemical Dependency Treatment Services

Honors and Awards

Departmental Distinction in Biology
Swarthmore College
Phi Beta Kappa
Swarthmore College
Derryberry Fellowship Award
University of California, Berkeley
Mack Lipkin Sr. Associate Award for Scientific Presentation
Society for General Internal Medicine
Clinical Faculty Scholars Program
Colorado Health Outcomes Program, University of Colorado, Denver
New Investigator Educator Award
Association for Medical Education and Research in Substance Abuse (AMERSA)
Professional Leadership Award/Women in Medicine and Science
University of Colorado, Denver
American College of Physicians
Clinician Investigator Award
Society for General Internal Medicine Mountain West Region
Most Downloaded Paper of 2016 Award
Substance Abuse Journal
Leadership for Innovative Team Science Program
Colorado Clinical and Translational Sciences Institute
Yale Drug Use, Addiction, and HIV Research Scholars (DAHRS) Advisory Committee
Yale School of Medicine

Scholarly Activities

View Dr. Ingrid Binswanger's Researcher Profile

Peer-reviewed research manuscripts
  • Finlay, A. K., Harris, A. H. S., Rosenthal, J., Blue-Howells, J., Clark, S., McGuire, J., Timko, C., Frayne, S., Smelson, D., Oliva, E., Binswanger, I. Receipt of pharmacotherapy for opioid use disorder by justice-involved status in Veterans Health Administration patients. Drug and Alcohol Dependence 2016; 160, 222-226. 
  • Binswanger IA, Morenoff JD, Chilcote CA, Harding DJ. Ascertainment of Vital Status among People with Criminal Justice Involvement using Department of Corrections Records, the U.S. National Death Index, and Social Security Master Death Files. American Journal of Epidemiology 2017; 185(10):982-985. 
  • Koester S, Mueller SR, Raville L, Langegger S, Binswanger IA. Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose? The International journal on drug policy 2017; Oct 48:115-124. 
  • Winkelman TNA, Frank JW, Binswanger IA, Pinals DA. Health Conditions and Racial Differences Among Justice-Involved Adolescents, 2009 to 2014. Academic pediatrics 2017; 17(7):723-731. 
  • Kennedy LC, Binswanger IA, Mueller SR, Levy C, Matlock DD, Calcaterra SL, Koester S, Frank JW. "Those Conversations in My Experience Don't Go Well": A Qualitative Study of Primary Care Provider Experiences Tapering Long-term Opioid Medications. Pain Med 2018; Nov 1; 19(11):2201-2211. 
  • Winkelman, TNA, Chang, VW, Binswanger IA. Health, Polysubstance Use, and Criminal Justice Involvement Among Adults with Varying Levels of Opioid Use. JAMA Network Open 2018;1(3).
  • Finlay, AK, Binswanger I, Timko C, Smelson D, Stimmel M, Yu M, Bowe T, Harris AHS. Facility-level changes in receipt of pharmacotherapy for opioid use disorder: Implications for implementation science. Journal of Substance Abuse Treatment 2018; Dec; 95:43-47. 
  • Fox A, Moore A, Binswanger IA, Kinner S. Deaths in Custody and Following Release. Journal of Health and Human Services Administration 2019; Spring;41(4): 44-83. 
  • Lapham G, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller I, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA. The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems. Substance Abuse 2019; Jan 18:1-10. 
  • Binswanger IA, Narwaney KJ, Gardner EM, Gabella BA, Calcaterra SL, Glanz JM. Development and evaluation of a standardized research definition for opioid overdose outcomes. Substance Abuse 2019; 2019;40(1):71-79.
  • Binswanger IA. Opioid Use Disorder and Incarceration: Hope for Ensuring the Continuity of Treatment. New England Journal of Medicine 2019; Mar 28;380(13):1193-1195.
  • Binswanger IA, Nguyen AP, Morenoff JD, Xu S, Harding DJ. The association of criminal justice supervision setting with overdose mortality: a longitudinal cohort study. Addiction. 2020;115(12):2329-2338.
  • Binswanger IA, Glanz JM, Faul M, Shoup JA, Quintana LA, Lyden J, Xu S, Narwaney K, The Association between Opioid Discontinuation and Heroin Use: A Nested Case-Control Study. Drug and Alcohol Dependence. 2020. Dec 1;217.
Book chapters
  • Hairston P, Binswanger IA. Addictions Treatment. In: Trestman RL, Appelbaum KL, Metzner JL, eds. Textbook of Correctional Psychiatry. 1st ed. New York, NY: Oxford University Press; 2015: 247-253.
  • Binswanger IA, Finlay A. Substance use and Consequences Among People Who Have Been Incarcerated: A Public Health Issue. In: Kinner S, Rich JD eds. Drug use in prisoners: Epidemiology, implications and policy responses. Oxford University Press; 2018. New York, NY.  
  • Binswanger IA, Glanz JM, Ford M. Epidemiology: Opioid Use and Related Disorders. Treating Opioid Addiction. Springer. Kelly, John F., Wakeman, Sarah (Eds.) 2019.